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S U M M A R Y
Background: Protein–polysaccharide vaccines have made a signiﬁcant impact on the burden of disease
caused by encapsulated bacteria such as Streptococcus pneumoniae, Haemophilus inﬂuenzae, Neisseria
meningitidis, and have the potential to do so for Salmonella Typhi. Nepal is one of many resource-poor
nations with limited information on the epidemiology of childhood infections caused by these pathogens.
Methods: Over a 21-month period, we studied children aged 12 years admitted to an urban hospital in
Nepal with suspected bacteremia, meningitis, or pneumonia. Patan Hospital is a non-proﬁt hospital with
the second largest pediatric unit in the Kathmandu Valley.
Results: Of 2039 children enrolled in the study, 142 (7.5%) included in the analysis had positive blood
cultures. The agents of enteric fever, Salmonella Typhi and Salmonella Paratyphi, accounted for 59/142
(42%) of all bacteremias and were the most frequently cultured pathogens in children 1 year of age. S.
pneumoniae was isolated in 16% of positive blood cultures and was the most common cause of
bacteremia in children <1 year of age. Pneumonia accounted for 51% of admissions in children 2
months, with 44% of these children having radiographically deﬁned primary endpoint pneumonia. S.
pneumoniae was the most commonly identiﬁed pathogen in cases of pneumonia and meningitis. The S.
pneumoniae serotype distribution indicated that the 10-valent and 13-valent pneumococcal conjugate
vaccines would cover 44% and 47%, respectively, of all S. pneumoniae cultured from blood or
cerebrospinal ﬂuid (CSF) isolates and 62% and 67%, respectively, of isolates associated with pneumonia.
H. inﬂuenzae type b was isolated infrequently from blood or CSF cultures, but is likely to be more
important as a cause of pneumonia.
Conclusions: The data on the burden of invasive bacterial infections and pneumonia from this study
suggest that vaccines in development against Salmonella Typhi and the pneumococcus have the
potential to signiﬁcantly improve the health of children in Nepal.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Encapsulated bacteria, such as Streptococcus pneumoniae,
Haemophilus inﬂuenzae type b (Hib), Neisseria meningitidis, and
Salmonella species, are principal causes of bacteremia, pneumonia,
and meningitis in childhood. Although meningitis and bacteremia* Corresponding author. Tel.: +44 (0)1865 234240; fax: +44 (0)1865 234242.
E-mail address: dominic.kelly@paediatrics.ox.ac.uk (D.F. Kelly).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2010.05.021are diseases with high rates of mortality, they are relatively low
incidence. In contrast, pneumonia is one of the most important
causes of child death, causing over 2 million deaths annually in
children under 5 years of age.1,2
The development of efﬁcacious protein–polysaccharide conju-
gate vaccines against S. pneumoniae, Hib, N. meningitidis, and
against enteric (typhoid) fever provides an opportunity to reduce
the burden of these diseases in children. The World Health
Organization (WHO) has recommended that vaccines against S.
pneumoniae and Hib should be a priority for introduction intoses. Published by Elsevier Ltd. All rights reserved.
Table 1
Clinical features used to identify afebrile childrenwith suspected pneumonia or invasive bacterial disease for inclusion in the study. Derived from South Asian Pneumococcal
Alliance (SAPNA) clinical standard operating procedures
Pneumonia Severe illness/sepsis Meningitis
 rapid breathing  inability to drink  bulging fontanelle
 lower chest wall indrawing  lethargic or unconscious  stiff neck
 cyanosis/hypoxemia  hypothermia <36 8C  reduced level of consciousness
 convulsion
 physician diagnosis of pneumonia clinically  physician diagnosis of septicemia  physician diagnosis of meningitis
or
 X-ray
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vaccination of children may be required to control enteric fever in
endemic areas.5 The Global Alliance for Vaccines and Immunisa-
tion (GAVI) has initiated speciﬁc programs and new funding
mechanisms in order to accelerate the introduction of both S.
pneumoniae and Hib vaccines into the developing world.6 Studies
of invasive bacterial infection in children have shown geographic
variation in the most prevalent pathogens,7–9 making the
acquisition of accurate regional data on disease burden a key
component in directing public health priorities.
Nepal is a low income country in South Asia with a population
of 25.8million people and an estimated infantmortality rate of 61/
1000 live births.10 Access to health care varies considerably within
the country, but as few as 18% of children under 5 years of age with
pneumonia are taken to health care facilities.11 There are only
limited data on the relative burden of disease due to bacterial
pathogens in Nepali children.
The principal aims of this study were to prospectively assess
the burden of community-acquired invasive bacterial disease
and pneumonia in children admitted to a hospital in urban
Nepal.
2. Methods
2.1. Setting
Patan Hospital is a non-proﬁt hospital with revenue generated
from patient charges. It is one of two large hospitals in Kathmandu
with pediatric referral and inpatient services. In 2001, the
Kathmandu Valley had a total population of approximately 1
645 091 people, with about 129 784 of these being children under
5 years of age.12 During the study period, pneumococcal conjugate
vaccines were not available in the country. Vaccines against Hib
and typhoidwere availablewithin the privatemarket, butwere not
widely used.
2.2. Recruitment
Children recruited into the study were those aged 12 years
who had been admitted to the pediatric ward at Patan Hospital
with fever (>38 8C) or who were afebrile but had a possible
clinical diagnosis of meningitis, pneumonia, or septicemia.
Standard clinical criteria were used to identify children with
these conditions (Table 1). At Patan Hospital the usual clinical
practice involved blood culture for all such individuals. Written
informed consent was obtained and then demographic and
clinical data were collected by research ofﬁcers and recorded
on standard forms. Exclusion criteria were the absence of a
blood culture, hospitalization for any illness in the 10 days
prior to the admission, and transfer directly from the neonatal
unit. The study was approved by the Nepal Health Research
Council and Oxford Tropical Research Ethics Committee
(OXTREC 026-04).2.3. Laboratory methods
Blood cultures were taken from all enrolled children, as per the
routine clinical practice within the hospital. Lumbar punctures
were performed at the discretion of the attending clinician. All
medical care was given by the hospital pediatric team according to
usual clinical practice. Every effort wasmade to ensure the prompt
transport of samples to the laboratory for incubation or, in the case
of cerebrospinal ﬂuid (CSF) samples, direct plating. The microbiol-
ogy laboratory was within the hospital, close to the clinical areas,
and samples were collected and processed at all times of the day.
Blood culture bottles were incubated at 35 8C and inspected
twice daily for turbidity. All samples had sub-cultures irrespective
of turbidity at 12–24 h and after 7 days of incubation. CSF samples
were directly plated onto sheep blood and chocolate agar and
incubated at 35 8C in a CO2 enriched environment for 24 h. CSF
samples with >5  106 white cells/l were tested by the NOW1
Streptococcus pneumoniae antigen test (Binax, Inc., Scarborough,
ME, USA). Isolation and identiﬁcation of microorganisms were
performed using standard microbiological tests. Isolates were
stored in Protect cryovials (Technical Service Consultants, Lanca-
shire, UK) at70 8C. Isolates of S. pneumoniae and Hib were sent to
the South Asian Pneumococcal Alliance (SAPNA) central laboratory
in Vellore, India for conﬁrmation, serotype identiﬁcation, and
antibiotic susceptibility testing. Serotyping was performed within
the Vellore laboratory using the Quellung method. The Patan
microbiology laboratory participated in a regular quality assurance
process directed by the SAPNA central laboratory in Vellore.
Urine samples taken at admission were frozen at 70 8C and
subsequently tested for antibiotic activity as described previous-
ly.13
CSF samples were stored at 70 8C prior to shipping to the
Health Protection Laboratory (Manchester, UK). Here, capsular
transport (ctrA), capsulation (bexA), and pneumolysin (ply) gene
targets speciﬁc for N. meningitidis, Hib, and S. pneumoniae,
respectively, were tested for by PCR using previously described
methods.14
Serum samples remaining after normal clinical care in 485
children were anonymized and stored at 70 8C. These were
subsequently tested for the presence of anti-HIV antibody
(Determine HIV-1/2, InvernessMedical, Cranﬁeld, UK) and positive
results were conﬁrmed by Western blotting.
2.4. Radiography
Chest radiographs were taken according to usual clinical
practice, which included all patients with pneumonia suspected
on clinical grounds. Portable X-ray facilities were available for very
sick children. Digital images of all radiographs were read by a
radiologist in Oxford, UK using the standardized WHO criteria.15
Radiographs were classiﬁed as showing: (1) primary endpoint
consolidation (likely bacterial pneumonia) – dense ﬂuffy consoli-
dation of a portion of a lobe or entire lung, whichmay be associated
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presence of non-endpoint inﬁltrate in the absence of a pleural
effusion; or (3) no consolidation/inﬁltration or pleural effusion.
Radiograph quality was also assessed according to standardized
WHO criteria to determine whether it was (1) sufﬁcient to
ascertain any of the outcomes described above (‘acceptable’), (2)
only sufﬁcient to ascertain the presence or absence of primary
endpoint consolidation (‘suboptimal’), or (3) unreadable.
2.5. Nutritional status
Weight for age Z-scores were calculated for each subject
(EpiInfo 2002; Centers for Disease Control and Prevention, Atlanta,
GA, USA).Moderate or severemalnutritionwas deﬁned as a Z-score
<2 and severe malnutrition was deﬁned as a Z-score <3.
2.6. Statistical analysis
Dichotomous and ordinal variables were tested by the Chi-
square test. The associations between bacteremia andmalnutrition
and between bacteremia and pre-hospital antibiotic use were
estimated byMantel–Haenszel odds ratios, stratiﬁed by age in four
strata: <60 days, 60–364 days, 1–5 years and >5 years. Data were
analyzed using Stata version 8.2 (StataCorp, College Station, TX,
USA).
2.7. Role of the funding source
The study sponsor had no role in the study design, in the
collection, analysis, and interpretation of data, in the writing of the
report, or in the decision to submit the paper for publication.
3. Results
3.1. Recruitment and demographics
A total of 2039 children were enrolled in the study between
April 1, 2005 and December 31, 2006. Information on total ward
admissionswas only available fromApril 24, 2005 to December 30,
2006 (88 of 91 weeks of the study). During that period 2335
children were eligible for recruitment, constituting 62% of total
admissions; 85.8% of those eligible were enrolled in the study.
Consequently 332 children were eligible but not enrolled. Of these,Table 2
Positive blood cultures by age group. For each organism the total number of positive
represents from among all positive cultures within that age group
Pathogen Age
0–59 days 60–3
Total blood cultures (excluding contaminants) 504 491
Total positive blood cultures (% of total blood cultures) 22 (4.4) 31 (
Positive cultures by organism (% total positive blood cultures within each age group)
Gram-positive
Streptococcus pneumoniae 0 9 (2
Staphylococcus aureus 3 (14) 3 (1
Group A streptococci 3 (14) 1 (3
Group B streptococci 1 (5) 0
Othersb 6 (27) 2 (6
Gram-negative
Haemophilus inﬂuenzae 0 1 (3
Salmonella Typhi/Paratyphi 2 (9) 4 (1
Escherichia coli 1 (5) 3 (1
Acinetobacter species 3 (14) 3 (1
Other Gram-negative rodsc 4 (18) 7 (2
a Polymicrobial bacteremia in three patients, hence the number of isolates is greate
b Species included Enterococcus (9), Streptococcus parasanguis (1), Aerococcus viridan
c Species included Pseudomonas (3), Serratia (4), Enterobacter (8), non-typhoidal Sa19 died before consent could be taken, 67 refused consent, and 130
had no blood culture taken; for 116 the reason for non-recruitment
was not recorded. Overall, 1166 of 2039 recruited children were
male (57%). Amongst 2017 children with a recorded weight, 730
(36%) had moderate or severe malnutrition and 304 (15%) had
severe malnutrition. There were 36 in-hospital deaths (2% of the
2039 children recruited) and 28 of these were children 1 year of
age. Amongst these children, the clinical diagnosis was meningitis
or encephalitis in three (8%), pneumonia in 17 (47%), septicemia in
11 (31%), and a variety of other diagnoses in ﬁve children (14%).
Only one of the 485 serum samples tested (0.2%) was positive for
HIV antibodies, and this was from a child aged <18 months.
3.2. Bacteremia
Blood cultures from 142 of the 2039 children (7%) grew
organisms considered to be contaminants. These patients were
excluded from further analysis of bacteremias. Of the remaining
1897 patients, bacteremia was identiﬁed in 142 (7.5%) (Table 2).
Where recorded, blood cultures were collected into BACTECTM
PEDS PLUSTM/F blood culture bottles (BD, Shannon Ireland) in 84%
of children and locally prepared culture bottles in 16%. The locally
prepared culture bottles performed at least as well as the
BACTECTM PEDS PLUSTM/F blood culture bottles in terms of
overall prevalence of identiﬁcation of bacteremia, but were more
likely to grow organisms considered to be contaminants (4.8% vs.
17%).
The prevalence of bacteremia increased with increasing age
(p < 0.0001). The agents of enteric fever, Salmonella Typhi (53
isolates) and Salmonella Paratyphi (6 isolates), were the most
common pathogens isolated in children 1 year old (59/142
(42%)). S. pneumoniae was the next most frequently cultured
organism and was the single most frequently cultured organism in
children <1 year of age; all except one episode in this age group
was associated with meningitis. After adjusting for age group,
therewas no association betweenmoderate or severemalnutrition
and bacteremia (odds ratio (OR) 0.92, 95% conﬁdence interval (CI)
0.64–1.33).
All S. Typhi and S. Paratyphi isolates were susceptible to
ampicillin, chloramphenicol, and ciproﬂoxacin, but 39 (66%) were
resistant to nalidixic acid. Only one S. pneumoniae isolate had
reduced susceptibility to penicillin (minimum inhibitory concen-
tration (MIC) 0.125 mg/ml).blood cultures is given for each age group together with the percentage that this
Rank
proportion
64 days 1–5 years >5 years Total
653 249 1897
6.3) 59 (9.0) 30 (12.0) 142 (7.5)a
9) 7 (12) 6 (20) 22 2
0) 2 (3) 3 (10) 11 3
) 1 (2) 0 5 –
0 0 1 –
) 2 (3) 2 (7) 12 –
) 1 (2) 0 2 –
3) 37 (63) 16 (53) 59 1
0) 0 0 4 –
0) 1 (2) 1 (3) 8 4
3) 8 (14) 2 (7) 21 –
r than the number of patients with bacteremia.
s (1), non-hemolytic Streptococcus (1).
lmonella (4), Stenotrophomonas maltophilia (1), Klebsiella (1).
Table 4
CSF culture/pneumococcal antigen testing/PCR results according to CSF white cell
count
No. of cases
Age No. of CSF
specimens
CSF white cell count
distribution
(cases with pathogen
identiﬁed), 106/l
Organism
<10 10–99 100 Spa Hibb Nmc
0–59 days 379 304 (1d) 56 (0) 19 (2) 1 1 1
60–364 days 100 67 (1d) 17 (2) 16 (7) 8 1 1
1–5 years 149 109 (0) 16 (0) 24 (5) 2 1 2
>5 years 72 36 (0) 14 (1) 22 (2) 3 0 0
Total 700 516 (2) 103 (3) 81 (16) 14 3 4
CSF, cerebrospinal ﬂuid; PCR, polymerase chain reaction; Sp, Streptococcus
pneumoniae; Hib, Haemophilus inﬂuenzae type b; Nm, Neisseria meningitidis.
Total numbers of bacteria identiﬁed for each group are for a combination of CSF
culture, BINAX antigen testing (for S. pneumoniae) and PCR for Sp, Hib and Nm.
Contribution of different methods of detection: aS. pneumoniae: CSF culture eight
cases, BINAX additional four cases, PCR additional two cases; bH. inﬂuenzae type b:
CSF culture three cases, PCR 0 cases; cN. meningitidis: CSF culture 0 cases, PCR
additional four cases. dTwo children had a pathogen identiﬁed by PCR only, but had
<10106/l white cells in the CSF and did not have a ﬁnal diagnosis of meningitis or
encephalitis: a 2-week infant with a diagnosis of pneumonia with CSF PCR positive
for S. pneumoniae and an 11-month-old with meningococcal septicemia with CSF
PCR positive for N. meningitidis.
Table 3
Odds ratios (with 95% conﬁdence intervals) for bacteremia in children with
evidence of pre-hospital antibiotic use, adjusted for age
Reported antibiotic use
(n=2013)
Urinary antibiotic activity
(n=457)
Any bacteremia 1.07 (0.73–1.57) 0.91 (0.45–1.86)
Typhoidal salmonella
bacteremia
2.82 (1.60–4.99) 1.73 (0.71–4.26)
Pneumococcal bacteremia 0.23 (0.07–0.80) 0.40 (0.05–3.00)
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of admission, and this was more common in children60 days old
(41%) compared with those <60 days old (8%) (p < 0.01). Pre-
hospital antibiotic use, as assessed by parental history or urine
antibiotic activity on admission, was analyzed for its effect on the
odds of detection of bacteremia (Table 3). There was no association
between pre-hospital antibiotic use and all-cause bacteremia.
However, pre-hospital antibiotic use, as assessed by parental
history, was associated with a reduced odds of pneumococcal
bacteremia and increased odds of Salmonella bacteremia. Analysis
of 457 urine samples collected on admission and prior to in-
hospital antibiotic treatment, demonstrated that in the 311
children with no history of antibiotic use, 98 (32%) had detectable
urinary antibiotic activity.
3.3. Meningitis
CSF samples were obtained for microbiological culture from
700 patients with suspected meningitis or encephalitis. Sufﬁcient
CSF was available for additional pneumococcal antigen testing in
84% and for PCR in 74% in samples with a CSF white cell count
[(Figure_1)TD$FIG]
Figure 1. Flow diagram to illustrate the number of children with a clinical diagnosis of pn
standardized World Health Organization criteria. CXRs of both ‘acceptable’ and ‘subopt
whereas only those with ‘acceptable’ quality could be assessed for less obvious inﬁltra
‘endpoint pneumonia’ are therefore given using a different denominator (640) to those>5  106/l. There was a discharge diagnosis of meningitis or
encephalitis in 23 out of 379 children (6%)<60 days of age and 101
out of 321 children (32%) 60 days of age. In these 124 children a
bacterial pathogen was identiﬁed in 19 (15%), with S. pneumoniae
the most common organism (Table 4). Out of the 124 children, 70
had a CSF sample collected after the administration of antibiotics in
hospital. For a history of administration of antibiotics prior to
hospital admission there was no discernible effect on CSF cultureeumonia and the associated blood culture results and chest X-ray (CXR) readings by
imal’ quality (n = 640) could be assessed for the presence of endpoint pneumonia,
tes or for the absence of any inﬁltrate (n = 526). The percentages of children with
children with ‘other inﬁltrate’ or ‘no radiological pneumonia’ (526).
Table 5
Serotype distribution of blood or CSF pneumococcal isolates from childrenwith and
without meningitisa
Pneumococcal serotype Number of isolates of Streptococcus pneumoniae
Non-meningitis,
blood culture
Meningitis,
blood/CSF culture
Total
1 10 0 10
12A 1 3 4
5 2 0 2
9A 2 0 2
9V 1 1 2
2 0 1 1
8 1 0 1
15A 0 1 1
16 0 1 1
18C 0 1 1
19A 1 0 1
19C 0 1 1
23B 0 1 1
25F 1 0 1
33 0 1 1
NT 2 2 4
Vaccine coverage
PCV7 1/21 (5%) 2/13 (15%) 3/34 (9%)
PCV10 13/21 (62%) 2/13 (15%) 15/34 (44%)
PCV13 14/21 (67%) 2/13 (15%) 16/34 (47%)
CSF, cerebrospinal ﬂuid; NT, non-typeable; PCV, pneumococcal conjugate vaccine
(7-, 10-, and 13-valent).
Serotypes are ordered by frequency of individual serotypes from combined
meningitis and non-meningitis cases. The data include an additional 10 isolates
from January 1, 2007 to September 30, 2007 in addition to the 24 from the study
period described in the current paper. Four CSF isolates had a blood culture S.
pneumoniae isolatewith different serotype (2, 9A, 25F and 25F) from that of CSF (NT,
9V, 12A and 19C, respectively).
aIn the original study period 22 children had pneumococcal bacteremia (Table 2)
and this group included eight children with meningitis. A total of 14 children had
evidence of pneumococcal meningitis, from positive CSF culture (n=8), negative
culture but positive Binax (n=4), or negative culture and Binax but positive PCR
(n=2) (Table 4). Only two of the children with CSF culture-positive pneumococcal
meningitis were not bacteremic and thus provided an additional two individuals
with pneumococcal isolates for serotyping in addition to the children with
bacteremia alone. This provided a total of 24 pneumococci from cases of invasive
disease for serotyping. A further 10 isolates were available from continued
surveillance in 2007, three from cases of meningitis and seven from non-meningitis
bacteremia.
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was a reduction in CSF culture positivity for samples collected after
the administration of antibiotics in hospital (age-adjusted OR 0.22;
95% CI 0.05–1.01).
3.4. Pneumonia
Aclinical dischargediagnosis of pneumoniawasmade in753of
the 1475 (51%) children 60 days old, the group most likely to
have pneumonia due to S. pneumoniae or Hib, with 44% of these
children having radiographically deﬁned primary endpoint
pneumonia. Digital copies of admission chest radiographs of
sufﬁcient qualitywere available for 640 (85%) of these children, as
shown in Figure 1. In children with endpoint pneumonia
(consolidation or pleural effusion) and no wheezing, 6% had
pneumococcal bacteremia. No child with a clinical diagnosis of
pneumonia and wheezing had pneumococcal bacteremia. There
were no isolates of Hib from children with a primary clinical
diagnosis of pneumonia.
Isolates of S. pneumoniae were obtained from 24 separate
children during the study period, and a further 10 were collected
during an additional 12 months of surveillance. Serotype data
for these isolates are shown in Table 5, together with the
proportion covered by various pneumococcal conjugate vaccine
formulations.4. Discussion
This study has demonstrated a signiﬁcant burden of enteric
fever, mainly due to Salmonella Typhi, and pneumonia, of which a
large proportion is likely to be caused by S. pneumoniae, amongst
children admitted to hospital in Kathmandu, Nepal. A subset of
these data, involving 885 children, has been published separately
in a supplement on pneumococcal disease.16
There are few systematic studies of bacteremia from resource-
poor countries in Asia. Among children aged 1–15 years in Laos,
Salmonella Typhi accounted for 60% of blood culture isolates,
followed by Staphylococcus aureus (17%) and enteric Gram-
negative bacilli (16%), with S. pneumoniae making up only 2% of
isolates.8 Studies from Africa are heavily inﬂuenced by high
prevalences of HIV infection and are notable for a high incidence of
non-typhoidal Salmonella bacteremia, accounting for between 7%
and 30% of isolates in different studies.7,17–20 This contrasts with
the higher incidence of infection with typhoidal salmonellae in
South Asia.8
The current study demonstrated a high prevalence of Salmo-
nella Typhi bacteremia. However this is an underestimate of the
true burden of enteric fever in Kathmandu, where this disease is
predominantly managed in the outpatient or community setting.
Population-based studies in Asia estimate that only 9% of enteric
fever cases are hospitalized.21 It is increasingly recognized that
Salmonella Typhi is an important pathogen of young children.21,22
In the current study, 73% of culture-conﬁrmed cases of enteric
fever were in children <5 years old and 28% in children <2 years
old. Although improvements in sanitation and water supply would
lead to a reduction in disease burden, such changes are unlikely to
occur in the short term and immunization is a major prevention
strategy. Currently available typhoid vaccines are only recom-
mended for use in children 2 years old.5,22 The development of
improved typhoid vaccines for use in young children is a high
priority for many countries in Asia.23,24
S. pneumoniae was the most common cause of bacteremia in
children under 1 year of age, where it was almost always
associated with meningitis, and overall the second most common
cause of bacteremia. S. pneumoniae was also the most common
pathogen identiﬁed causing meningitis. Pneumonia is one of the
leading causes of childhood mortality in children 5 years of age,2
and S. pneumoniae is one of the most important pathogens. In the
present study, over 50% of children2 months old had a discharge
diagnosis of pneumonia; however it is more difﬁcult to establish
the etiology of bacterial pneumonia than of meningitis. A trial of a
9-valent pneumococcal conjugate vaccine in The Gambia indicated
that 7.5 times the number of cases of radiographic pneumonia
were prevented for every one culture-positive case.25 In our study,
6% of children with endpoint pneumonia and no wheeze had a
blood culture positive for S. pneumoniae. Using the same ratio of
pneumonia cases prevented per culture-positive case would give
75 children in the current study who had pneumococcal
pneumonia. This would represent 46% of all endpoint pneumonia
without wheeze or 27% of all endpoint pneumonia. These ﬁgures
are in keeping with the estimate of 20–35% from the vaccine probe
studies.26,27 Although the vaccine probe studies were conducted in
children under the age of 5 years, in the present study the
proportion of cases of radiographically conﬁrmed pneumonia with
a blood culture positive for S. pneumoniae was higher in those
children >5 years of age compared to those under the age of 5
years, suggesting the continued importance of this organism in the
older children.
Antibiotics are freely available within urban areas of Nepal and
their use in children prior to admission to hospital might be
expected to inﬂuence the detection of bacteremia. In the current
study a history of pre-hospital antibiotic usage made it less likely
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cannot be excluded that this is due to the rapid deterioration of
such children before there is time to administer antibiotics, this
seems unlikely for a disease such as pneumonia. These data
suggest that the estimates derived above are aminimal estimate of
hospital disease burden.
The serotype distribution of pneumococcal isolates from the
current study and the following 12months (Table 5) indicates that
the 10- and 13-valent pneumococcal conjugate vaccines would
provide coverage of around half of all cases of invasive
pneumococcal disease in children 12 years of age. Importantly
the proportion of isolates covered is much greater for the
pneumococci isolated from children with pneumonia (62–67%)
as opposed to those with meningitis (15%). Although the latter is a
more severe illness, the incidence of pneumonia, the majority of
which is non-bacteremic, is far higher. More deaths occurred from
pneumonia than from meningitis during the study period. Recent
estimates of the global disease burden due to S. pneumoniae
reinforce the importance of the disease burden due to pneumonia.
For Southeast Asia it is estimated that the annual incidence of
pneumonia is 2911 cases per 100 000 children under 5 years of age
with 169 000 deaths per year in comparison with meningitis for
which the estimates are 13 cases per 100 000 and 13 700 deaths
per year.28
Although there has been controversy over the importance of
Hib as a cause of invasive disease in Asia,29 Hib has been identiﬁed
as a cause of pneumonia, bacteremia, and meningitis in many
regions of South Asia.30,31 In the present study Hib constituted 2%
of all bacteremias. This is a similar prevalence to that recorded in
Laos,8 but is in contrast to the documented prevalence in Africa
where Hib constitutes 9–14% of bacteremias.7,17,20 It is unclear
whether this difference reﬂects actual differences in the incidence
of Hib disease between the different populations.32 The estimated
incidence of Hib meningitis varies widely by global region, ranging
from 16 to 46 cases per 100 000 children <5 years of age per year
with an estimate of 27 per 100 000 for Southeast Asia.33 There
were only a small number of cases of Hib bacteremia and all were
associated with a diagnosis of meningitis. This is consistent with
several studies that have shown that Hib bacteremia with
pneumonia occurs less frequently than cases of meningitis.34–37
It is unclear whether pre-hospital antibiotic usage affected the
number of Hib isolates, as the number of cases was relatively
low.38 However, studies of Hib carriage in children in Kathmandu
have indicated similar levels of nasopharyngeal carriage to those
seen in areas where there is a high prevalence of disease.39 Despite
the severity of meningitis, the greatest burden of Hib disease is
likely to be due to its role as an agent of pneumonia where it is
more difﬁcult to establish an etiological agent.
The information onHib from the current study is similar to that
at the other major pediatric unit in Kathmandu.40 At Kanti
Hospital, Hib was the second most common isolate cultured from
CSF in children aged 2 months to 5 years after S. pneumoniae, and
there were no episodes of Hib bacteremia in cases of meningitis.
Although the incidence of Hib bacteremia associated with a
primary diagnosis of pneumonia was too low to detect in the
current study, the WHO has suggested using a ratio of 5:1 for
estimating the burden of disease due to non-bacteremic Hib
pneumonia from meningitis cases in children 2 years old.41 In
the current study this would give around 15 cases of Hib
pneumonia from 55 children 2 years old with clinical and
radiographic pneumonia and no wheeze. This ﬁgure of 27% of
cases is within the range indicated by previous vaccine probe
studies of 15–30% of radiographic pneumonia for children under 5
years of age.26 If Hib were similarly prevalent in pneumonia in
children aged 2–5 years, this would give 27 cases of Hib
pneumonia in this age group.Patan Hospital is a non-proﬁt hospital with revenue generated
from patient charges. Whilst this may bias the data in terms of the
patient population that is seen, the hospital charges are small
enough that they are not considered by local medical staff as a
signiﬁcant deterrent to presentation with an ill child. In terms of
comparison to government hospitals, a study of pneumococcal and
Hib disease undertaken at Kanti Hospital in Kathmandu as part of
the SAPNA network had comparable mortality and pre-hospital
antibiotic use reported.40
Vaccine preventable bacterial diseases are important causes of
hospitalization in the children of Kathmandu. In this study
meningitis and bacteremia due to Salmonella Typhi, S. pneumoniae,
and Hib, together with estimates of pneumonia due to S.
pneumoniae and Hib, indicate that over one in 10 of all children
2 months of age had diseases that in principal are preventable
through immunization. These data estimate the incidence of
disease severe enough to require hospitalization and substantially
underestimate the true burden of these diseases in the community.
Immunization programs directed against bacterial pathogens are
likely to make a major impact on childhood illness in Nepal.
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